REFERENCES
- Berger, R. L., Hsu, J.C. (1996), Bioequivalence trials, intersection–union tests and equivalence confidence sets. Statistical Science 11(4):283–319.
- Chang, Y.-W., Tsong, Y., Dong, X. (2014). Sample size determination for a three-arm equivalence trial of normally distributed responses. Journal of Biopharmaceutical Statistics 24(6):XX–XX.
- Chinchilli, V. M. and Esinhart, J. D. (1996). Design and analysis of intra-subject variability in crossover experiments. Statistics in Medicine 15:1619–1634.
- Chow, S.-C. (1999). Individual bioequivalence—A review of the FDA draft guidance. Drug Information Journal 33:435–444.
- Chow, S.-C., Hsieh, T.-C., Chi, E., Yang, J. (2010). A comparison of moment based and probability-based criteria for follow-on biologics. Journal of Biopharmaceutical Statistics 20:1, 31–35.
- Dong, X., Tsong, Y. (2014). Equivalence assessment for interchangeability based on two sided tests. Journal of Biopharmaceutical Statistics 24(6):XX–XX.
- Esinhart, J. D., Chinchilli, V. M. (1994). Sample size considerations for assessing individual bioequivalence based on the method of tolerance interval. International Journal of Clinical Pharmacology and Therapeutics 32:1, 26–32.
- Esinhart, J. D., Chinchilli, V. M. (1994). Extension to the use of tolerance interval for assessment of individual bioequivalence. Journal of Biopharmaceutical Statistics. 4:1, 39–52.
- Food and Drug Administration. (1999). FDA Draft Guidance for Industry. Average, Population, and Individual Approaches to Establishing Bioequivalence. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration.
- Food and Drug Administration. (2001). FDA Guidance for Industry. Statistical Approach to Establishing Bioequivalence. U.S. Department of Health and Human Services. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration.
- Food and Drug Administration. (2003). FDA Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products—General Considerations. U.S. Department of Health and Human Services. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration.
- Hall, I. J. (1984). Approximated one-sided tolerance interval for the difference or sum of two independent normal variables. Journal of Quality Technology 16:15–1.
- Liu, J-P., Chow, S.-C. (1999). Some thoughts on individual bioequivalence. Journal of Biopharmaceutical Statistics 16:861–874.
- Tse, S.-K., Chang, J.-Y., Su, W.-L., Chow, S.-C., Hsiung, C., Lu, Q. (2006). Statistical quality control process for traditional Chinese medicine. Journal of Biopharmaceutical Statistics 7(1):41–48.
- Tsong, Y., Shen, M. (2007). An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response. Journal of Biopharmaceutical Statistics 17:329–338.
- Tsong, Y., Shen, M., Lostritto, R.T., Poochikian, G.K. (2008). Parametric two-tier sequential quality assurance test of delivery dose uniformity of multiple-dose inhaler and dry powder inhaler drug products. Journal of Biopharmaceutical Statistics 18(5):976–984.